Vigabatrin.

Dari Yasunli Enterprise Software
Revisi per 22 November 2024 06.04; JohnnieWeathers (bicara | kontrib)

(beda) ←Revisi sebelumnya | Revisi terkini (beda) | Revisi selanjutnya→ (beda)
Langsung ke: navigasi, cari

Tell your healthcare provider right now if you (or your kid): might not be seeing as well as before starting SABRIL; start to trip, bump into things, or are a lot more clumsy than usual Bookmarks; are shocked by individuals or points coming in front of you that seem to come out of no place; or if your baby is acting in a different way than typical.

SABRIL (vigabatrin) is a prescription medication used with other treatments in grownups and children 2 years of age and older with refractory facility partial seizures (CPS) that have not reacted well enough to a number of various other therapies and if the feasible benefits surpass the threat of vision loss.

It is recommended that your healthcare provider test your (or your child's) vision prior to or within 4 weeks after beginning SABRIL and at least every 3 months during treatment until SABRIL is stopped. If you or your youngster have any type of side result that bothers you or that does not go away, tell your health care company.

Inform your healthcare provider if you are pregnant or plan to get expectant. If vision testing can not be done, your healthcare provider may proceed recommending SABRIL, yet will certainly not be able to expect any kind of vision loss. If vision tests are refrained from doing routinely, your doctor may quit prescribing SABRIL for you (or your kid).